Nigeria has recorded 877 new cases of the novel Coronavirus, bringing the total number of confirmed infections in the country to 150,246.
Announcing the new figures in a late night tweet on Thursday, the Nigeria Centre for Disease Control (NCDC) disclosed that the country also recorded 16 new COVID-19 related deaths in the last 24 hours under review.
The Health Agency said the new cases were reported from 26 states including the Federal Capital Territory FCT.
According to the NCDC, of the new cases, 273 were recorded in Lagos, 87 in Kaduna, 58 in Rivers and 58 in Akwa Ibom.
Other states with new cases include, 47 Ebonyi-47 Edo-46 Ogun-46 Abia-34 Imo-34 Kano-34 Oyo-26 Osun-22 Gombe-20 Ekiti-19 Cross River-15 FCT-15 Plateau-11 Enugu-9 Kebbi-8 Borno-7 Niger-6 Bayelsa-5 Nasarawa-4 Kwara-2 Katsina-1 Sokoto-1.
NCDC said till date, 150,246 cases have been confirmed, 12,6417 treated and discharged and 1,803 deaths have been recorded in 36 states and the Federal Capital Territory FCT.
The Centre said a multi-sectoral national emergency operations centre (EOC), activated at Level 3, continues to coordinate the national response activities nationwide.
The Nigeria’s public health institute said that there were now over 22 thousand active cases across the country in the last 24 hours.
The country has so far tested 1,441,013 people since the first confirmed case relating to the COVID-19 pandemic was announced on Feb. 27, 2020.
Meanwhile, the National Agency for Food and Drug Administration and Control, NAFDAC, has approved the AstraZeneca/Oxford COVID-19 vaccine for use in Nigeria.
The approval came on the heels of the World Health Organisation’s listing of the vaccine for emergency use on Monday.
Announcing the approval at a media briefing in Abuja yesterday, NAFDAC Director-General, Prof. Mojisola Adeyeye, said the evaluation of AstraZeneca/Oxford vaccine, codenamed Covisheild (AZD1222), showed it was effective against the variant of the coronavirus first discovered in the UK, several cases of which had been reported in Nigeria.